Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,693 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The steatosis-associated fibrosis estimator score is a useful indicator of recurrence and survival after initial curative hepatectomy for hepatocellular carcinoma.
Bekki T, Ohira M, Imaoka Y, Hattori M, Nakano R, Sakai H, Kuroda S, Tahara H, Ide K, Kobayashi T, Ohdan H. Bekki T, et al. Among authors: sakai h. Ann Gastroenterol Surg. 2024 Jul 23;9(1):178-187. doi: 10.1002/ags3.12846. eCollection 2025 Jan. Ann Gastroenterol Surg. 2024. PMID: 39759992 Free PMC article.
Arteriosclerosis Decreases Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression on Liver Natural Killer Cells in Living Donor Liver Transplantation.
Imaoka K, Ohira M, Bekki T, Sato K, Imaoka Y, Nakano R, Yano T, Sakai H, Tanimine N, Shimizu S, Doskali M, Kuroda S, Tahara H, Ide K, Kobayashi T, Tanaka Y, Ohdan H. Imaoka K, et al. Among authors: sakai h. Transplant Proc. 2023 May;55(4):906-912. doi: 10.1016/j.transproceed.2023.03.066. Epub 2023 Apr 22. Transplant Proc. 2023. PMID: 37095010
Protocol to evaluate the efficacy and safety of tolvaptan in patients with refractory ascites after liver resection: an open-label, single-arm phase I/II study.
Namba Y, Kobayashi T, Kuroda S, Hashimoto M, Takei D, Fukuhara S, Oshita K, Matsubara K, Honmyo N, Nakano R, Sakai H, Tahara H, Ohira M, Ide K, Ohdan H. Namba Y, et al. Among authors: sakai h. Int J Surg Protoc. 2023 Dec 15;28(1):1-5. doi: 10.1097/SP9.0000000000000015. eCollection 2024 Mar. Int J Surg Protoc. 2023. PMID: 38433869 Free PMC article.
Immunotherapy Using Activated Natural Killer Cells Improves Postoperative Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver Transplant Recipients With Hepatocellular Carcinoma.
Imaoka K, Ohira M, Hattori M, Chogahara I, Sato S, Nakamura M, Bekki T, Sato K, Imaoka Y, Nakano R, Yano T, Sakai H, Kuroda S, Tahara H, Ide K, Kobayashi T, Tanaka Y, Ohdan H. Imaoka K, et al. Among authors: sakai h. Transplant Proc. 2024 Apr;56(3):634-639. doi: 10.1016/j.transproceed.2024.02.002. Epub 2024 Mar 4. Transplant Proc. 2024. PMID: 38443302
A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation.
Ohira M, Imaoka Y, Sato K, Imaoka K, Bekki T, Yano T, Nakano R, Sakai H, Kuroda S, Tahara H, Ide K, Kobayashi T, Tanaka Y, Tanaka J, Ohdan H. Ohira M, et al. Among authors: sakai h. PLoS One. 2025 Jan 16;20(1):e0313102. doi: 10.1371/journal.pone.0313102. eCollection 2025. PLoS One. 2025. PMID: 39820189 Free PMC article. Clinical Trial.
4,693 results